AGP Limited (PSX:AGP)

Market Cap	52.19B
Revenue (ttm)	27.73B
Net Income (ttm)	3.69B
Shares Out	280.00M
EPS (ttm)	13.19
PE Ratio	14.13
Forward PE	11.17
Dividend	4.00 (2.08%)
Ex-Dividend Date	Sep 2, 2025

Volume	349,479
Average Volume	385,848
Open	192.21
Previous Close	192.20
Day's Range	185.01 - 193.00
52-Week Range	142.00 - 220.02
Beta	0.27
RSI	38.47
Earnings Date	Oct 30, 2025

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 2,143
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.